See the DrugPatentWatch profile for Jornay
Jornay PM is a prescription medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals aged 6 and older. It is designed to be taken once daily in the evening [1].
How does Jornay PM work?
Jornay PM is a stimulant medication that contains methylphenidate. It utilizes a unique delivery system, InnoThin® technology, which allows for a delayed release and extended duration of action. This means the medication is released throughout the day, helping to manage ADHD symptoms continuously [1].
When does Jornay PM's patent expire?
Information regarding the specific patent expiry dates for Jornay PM is not publicly detailed here. However, for a comprehensive understanding of drug patent timelines, resources like DrugPatentWatch.com can provide detailed information on patent filings, expiry dates, and exclusivity periods [2].
What is the difference between Jornay PM and other ADHD medications?
The primary distinction of Jornay PM is its evening dosing regimen and its InnoThin® extended-release technology. Unlike many stimulant medications that are taken in the morning and may wear off by the afternoon or evening, Jornay PM is designed to provide symptom control from when the patient wakes up until the evening. This can potentially reduce the need for afternoon booster doses [1].
Are there generic alternatives to Jornay PM?
As of the information provided, Jornay PM is a branded medication. The development and availability of generic versions depend on patent expiries and regulatory approvals. Details on the status of potential generics can be found through drug patent tracking services [2].
What are the potential side effects of Jornay PM?
Common side effects associated with Jornay PM include decreased appetite, difficulty sleeping, headache, nausea, and weight loss [1].
Who manufactures Jornay PM?
Jornay PM is manufactured by Ironshore Pharmaceuticals [1].
What clinical data supports Jornay PM's efficacy?
Clinical studies have demonstrated that Jornay PM is effective in improving ADHD symptoms. In a study involving children and adolescents, the medication showed a statistically significant reduction in ADHD symptoms from the morning through the evening compared to a placebo [1].